DORA Stakeholder Meeting E-Prescribing Rule-Making January 24, 2020

January 15, 2020

Stakeholder Meeting - January 24, 2020

The Colorado Podiatry Board, the State Board of Optometry, the Colorado Dental Board, the Colorado Medical Board, and the Board of Nursing will hold a Stakeholder Meeting to receive input regarding the implementation of Colorado Senate Bill 19-079 (SB19-079) as it relates to the requirement that physicians, physician assistants, podiatrists, dentists, advanced practice nurses with prescriptive authority, and optometrists prescribe controlled substances electronically on or after July 1, 2021 unless a statutory exception applies. Dentists must prescribe controlled substances electronically on or after July 1, 2023 unless a statutory exception applies.   

Draft Rules

  • A copy of the draft rules and SB19-079 are available for download. 

Meeting Information

  • Friday, January 24, 2020, at 1:30 P.M.

Ways to Participate

  • In Person: Civic Center Plaza, 1560 Broadway, Room 110D (1st Floor), Denver, CO 80202
  • By Webinar: Register Here
  • Submit Comments: Oral comments will be taken from participants who are present in-person or participating via webinar. If you cannot make the meeting in-person or wish to make written comments rather than speaking, you may email your written comments to: [email protected] by Tuesday, January 21, 2020, to be included in the dialogue of this Stakeholder Meeting. However, public comments are encouraged and will be accepted until the Permanent Rulemaking Hearings.  

Meeting Format

Stakeholder input will be limited to discussions on the implementation of SB19-079. The Boards need your help to identify how these changes might affect consumer outcomes, positive or negative, and to assess “how” and “what” changes should be considered to implement the new legislation. Written and oral comments will be available for the Board to consider as part of the formal rulemaking process. If you have any questions or concerns about stakeholder input, please send them to [email protected].